Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New AI Software Accurately Detects Lung Cancers on X-Rays and Cuts Unnecessary Chest CT Scans by 30%

By MedImaging International staff writers
Posted on 06 Aug 2021
A recent study has shown that a deep learning-based artificial intelligence (AI) algorithm can improve the performance of readers in detecting lung cancers on chest radiographs.

According to the second joint study conducted by Massachusetts General Hospital (Boston, MA, USA) and Lunit Inc. (Seoul, Korea), AI had 28% sensitivity benefit for radiology residents, helping them properly recommend CT exams for potential lung cancer patients, and 30% specificity benefit for radiologists in lung cancer detection, reducing unnecessary CT exams. The joint research team has previously focused on validating the accuracy of AI, and proved that Lunit INSIGHT CXR, an AI software for analyzing chest X-rays, can accurately detect malignant pulmonary nodules, which can cause lung cancer. In this consecutive study, the team focused on whether AI can affect the performance of medical professionals in finding lung cancers.

For the study, 519 images of cancer-positive and cancer-negative patients were selected from the National Lung Screening Trial (NLST). Eight readers, including three radiology residents and five board-certified radiologists, participated in the reading. By comparing the analysis of the readers and Lunit INSIGHT CXR, the result showed that AI could lead to more efficient and precise diagnosis for both doctors and patients. With AI, radiology residents were able to recommend 28% more chest CT examinations for patients who may have potential risk of lung cancer. Also, radiologists recommended about 30% lesser proportion of unnecessary chest CT examinations in cancer-negative patients.

"The use of AI could help to detect pulmonary nodules accurately with chest X-rays, as well as reduce the need for unnecessary chest CT exams in some patients," said Mannudeep K. Kalra, MD, a radiologist at the MGH and Co-investigator on the study. "This finding can benefit patients by enabling them to avoid unneeded radiation exposure, and it can benefit the healthcare system by preventing certain medical costs."

"Chest X-ray is the firsthand diagnostic tool to detect lung cancer, but it has limitations as it is a compressed 2D rendering of 3D human structures," said Brandon Suh, CEO of Lunit. "An accurate analysis through Lunit INSIGHT CXR can help medical professionals provide diagnosis to patients with increased efficiency - preventing potential cancer at an early stage, while saving time and cost for those who do not need a further examination."

Related Links:

Massachusetts General Hospital
Lunit Inc.



Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Enterprise Imaging & Reporting Solution
Syngo Carbon
Ultrasound Needle Guide
Ultra-Pro II
New
1.5T MRI System
uMR 670
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get complete access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.